SCHEMBL29434869

SCHEMBL29434869

Oc1ccc(-c2ccc(Cl)cc2F)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 10/20 0.52
ESR2 Q92731 4/20 0.52
CYP2C19 P33261 4/20 0.47
APP P05067 3/20 0.47
CYP2C9 P11712 3/20 0.47
CYP3A4 P08684 3/20 0.47
CYP2D6 P10635 2/20 0.46
FASN P49327 1/20 0.45
GRM2 Q14416 1/20 0.44
MEN1 O00255 2/20 0.44
MAPT P10636 2/20 0.44
KMT2A Q03164 2/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
HSD17B1 P14061 1/20 0.42
HSD17B2 P37059 1/20 0.42
PDE3B Q13370 1/20 0.42
PDE3A Q14432 1/20 0.42
USP2 O75604 1/20 0.41
CYP1A2 P05177 1/20 0.41
ALOX15 P16050 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17217161 1.00 ESR1 (0.52) ESR1ESR2CYP2C19APPCYP2C9
SCHEMBL15596256 0.88 ESR1 (0.61) ESR1ESR2CYP2C19APPCYP2C9
SCHEMBL23638836 0.87 GRM2 (0.49) ESR1ESR2FASNGRM2SMN1; SMN2
SCHEMBL31067155 0.83 NPC1 (0.49) CYP2C19APPCYP2C9CYP3A4FASN
SCHEMBL20898100 0.83 NPC1 (0.49) CYP2C19APPCYP2C9CYP3A4FASN
SCHEMBL38659424 0.83 ESR1 (0.70) ESR1ESR2CYP2C19APPCYP2C9
SCHEMBL28226426 0.83 ESR1 (0.70) ESR1ESR2CYP2C19APPCYP2C9
SCHEMBL28901881 0.82 ESR1 (0.53) ESR1ESR2CYP2C19APPCYP2C9
SCHEMBL9858166 0.81 ESR1 (0.57) ESR1ESR2CYP2C19APPCYP2C9
SCHEMBL29901376 0.81 ESR1 (0.57) ESR1ESR2CYP2C19APPCYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109503686-B Novel nucleoside phosphoramidate compounds and uses thereof 南京圣和药业股份有限公司 2022-03-11 CN disclosed